Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Riken
Biotech
Lynk inks $50M series B for 3 early-stage trials
Lynk Pharmaceuticals has another $50 million bankroll phase 1 and 2 clinical trials of its myelofibrosis and inflammatory bowel disease candidates.
Kyle LaHucik
Aug 27, 2021 9:55am
Bayer forms drug discovery pact with Japan's Riken Innovation
Oct 9, 2019 8:25am
Stroke treatment normalizes brain fluids, restores movement in mice
May 13, 2019 3:00pm
